Asia Pacific: The Asia Pacific region is projected to exhibit rapid market growth for Direct-to-Consumer Genetic Testing, driven by factors such as increasing prevalence of genetic disorders, growing adoption of advanced healthcare technologies in countries like China, Japan, and South Korea.
Europe: In Europe, countries like the United Kingdom, Germany, and France are expected to contribute to the growth of the Direct-to-Consumer Genetic Testing Market, owing to the rising incidence of chronic diseases, advancements in genetic testing technologies, and increasing focus on preventive healthcare measures.